Full name
INSTYTUT DIABETOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
INSTYTUT DIABETOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RACŁAWICKA 129 / 2U, 02-117 WARSZAWA
TAX ID9522125308
Rate company:
INSTYTUT DIABETOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9522125308
KRS0000467973
Share capital5,000.00 zł
address
UL. RACŁAWICKA 129 / 2U, 02-117 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9522125308
REGON
146774961
KRS
0000467973
Legal form
limited liability company
Register Address
UL. RACŁAWICKA 129 / 2U, 02-117 WARSZAWA
Date of registration in KRS
2013-07-11
Date of commencement of economic activity
2013-07-11
Act signature
RDF/642070/24/17
Pkd codes
86.22.Z - Specialist medical practice activities
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.21.Z - General medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
96.04.Z - Physical well-being activities
Payer VAT status
Active
Vat list bank account(s)
PL55 2530 0008 2057 1021 6073 0003 
PL12 2530 0008 2057 1021 6073 0001 PL82 2530 0008 2057 1021 6073 0002 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,1 | 0,1 | 0,3 | 499,4 |
EBITDA | 0,3 | 0,3 | 0,4 | 33,4 |
Short time liabilities | 0,2 | 0,2 | 0,1 | -16,8 |
Equity capital | 1 | 1,1 | 1,4 | 26,3 |
Operating profit (EBIT) | 0,2 | 0,2 | 0,3 | 44,6 |
Assets | 2,8 | 2,7 | 2,9 | 5,2 |
Net profit (loss) | 0,1 | 0 | 0,3 | 554,2 |
Cash | 0,1 | 0,1 | 0,1 | 29 |
Net income from sale | 1,7 | 2,1 | 2,6 | 26,9 |
Liabilities and provisions for liabilities | 1,8 | 1,6 | 1,5 | -8,9 |
Working assets | 0,4 | 0,3 | 0,5 | 73 |
Depreciation | 0,1 | 0,1 | 0,1 | 4,8 |
% | % | % | p.p. | |
Profitability of capital | 13,4 | 4 | 20,8 | 16,8 |
Equity capital to total assets | 37 | 45,4 | 59,5 | 14,1 |
Gross profit margin | 8,6 | 2,4 | 11,5 | 9,1 |
EBITDA Margin | 17,3 | 14,5 | 15,3 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 52 | 31 | 20 | -11 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
OrtoGo Centrum Medyczne Sp. z o.o.
Warszawa
BOGUMIŁA KĘPA Bogumiła Kępa
Świdnica
Klinika GALENA
Bielsko-Biała
Telemedycyna Polska S.A.
Katowice